Rifaximin for the treatment of hepatic encephalopathy.
PURPOSE: The use of rifaximin for the treatment of hepatic encephalopathy (HE) is reviewed. SUMMARY: HE is observed in approximately 50-70% of all patients with cirrhosis. Clinical manifestations of HE range from altered mental status to deep coma. Most manifestations of this syndrome are reversible...
| Publicado en: | American Journal of Health-System Pharmacy Vol. 65; no. 9; pp. 818 - 823 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
Oxford University Press / USA
5/1/2008
|
| Acceso en línea: | Ver este registro en EBSCOhost |